Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Eligix cleared to initiate pivotal trial of DLI purification technology

July 28, 1999

AHP's pneumococcal conjugate vaccine receives priority review status

July 27, 1999

ProdiGene patents edible vaccines

July 23, 1999

Inhibitors of Src family SH2 domains in early-stage development at Boehringer Ingelheim

July 22, 1999

Novartis exercises option to license complement inhibitor from Avant

July 21, 1999

Rotavirus vaccine temporarily suspended due to reports of intussusception

July 20, 1999

Takeda patents inhibitors of ICAM-1/ELAM-1 expression for immune, autoimmune disorders

July 20, 1999

Cantab's therapeutic vaccine for genital warts enters phase II trials

July 20, 1999

New topical ciclosporin formulation effective for site-specific immunosuppression

July 20, 1999

Tanox tests Hu-901 in peanut allergy

July 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...